Perspectives on the 2018 HHS Drug Pricing Guidance

This is the agenda for the Brazda Breakfast: Reporting on the Future of Health Care titled "Perspectives on 2018 HHS Drug Pricing Guidance" held on May 15, 2018, in Washington D.C.

9:00 a.m. – 9:05 a.m.   Welcome and Introductions

  • William Pierce, MPIA, senior director, APCO Worldwide
  • Mary Ella Payne, R.N., MSPH, acting president and chief executive officer, Alliance for Health Policy

9:05 a.m. – 9:35 a.m.   Perspectives from the Administration

  • Scott Gottlieb, M.D., Commissioner of Food and Drugs, U.S. Food and Drug Administration

9:40 a.m. – 10:30 a.m. Perspectives from Stakeholders

  • Lauren Aronson, executive director, Campaign for Sustainable Drug Pricing
  • Kristin Bass, MBAsenior vice president, Policy and Federal Affairs, Pharmaceutical Care Management Association
  • Justine Handelman, senior vice president, Office of Policy and Representation, Blue Cross Blue Shield Association
  • Lori Reilly, J.D., executive vice president, Policy, Research, and Membership, Pharmaceutical Research and Manufacturers of America